Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Molecular Genetics & Genomic Medicine|April 20, 2026
A Complex Neurodevelopmental Phenotype Resembling a Chromatinopathy With Concurrent 7p Duplication and 10p Deletion Involving ZMYND11: A Case Report and Literature ReviewElia Marco Paolo Minale, Stefania Martone, Chiara Criscuolo, et al.International Journal of Molecular Sciences|October 14, 2022
Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable AlterationsFabio Pastorino, Mario Capasso, Chiara Brignole, et al.Frontiers in Nutrition|September 6, 2023
Impact of active lifestyle on the primary school children saliva microbiota compositionAnnamaria Mancini, Claudia Cerulli, Daniela Vitucci, et al.Cancer Cell International|April 30, 2022
FGFR1 is a potential therapeutic target in neuroblastomaFlora Cimmino, Annalaura Montella, Matilde Tirelli, et al.Journal of Cellular and Molecular Medicine|February 28, 2020
Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastomaMarianna Avitabile, Vito Alessandro Lasorsa, Sueva Cantalupo, et al.Molecules (Basel, Switzerland)|February 15, 2022
A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human IntestineLorella Paparo, Maria Antonia Maglio, Maddalena Cortese, et al.Ebiomedicine|December 9, 2022
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastomaFerdinando Bonfiglio, Vito Alessandro Lasorsa, Sueva Cantalupo, et al.Human Genomics|November 6, 2024
Best practices for germline variant and DNA methylation analysis of second- and third-generation sequencing dataFerdinando Bonfiglio, Andrea Legati, Vito Alessandro Lasorsa, et al.British Journal of Cancer|May 19, 2020
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinaseFrancesca Maria Orlandella, Raffaela Mariarosaria Mariniello, Peppino Mirabelli, et al.Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.Pageof 4